Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.795
+0.075 (1.59%)
At close: Mar 20, 2026, 4:00 PM EDT
5.05
+0.26 (5.32%)
After-hours: Mar 20, 2026, 4:27 PM EDT
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $56.65 million as of March 20, 2026. Its market cap has increased by 19.19% in one year.
Market Cap
56.65M
Enterprise Value
33.63M
1-Year Change
19.19%
Ranking
Category
Stock Price
$4.80
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $56.65M, a decrease of -22.24%. That is a compound annual growth rate of -5.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 49.94M | -15.50% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 59.63M |
| TScan Therapeutics | 59.18M |
| Immutep | 57.94M |
| Instil Bio | 57.78M |
| MindWalk Holdings | 57.61M |
| OnKure Therapeutics | 57.29M |
| ImmuCell | 54.91M |
| Actuate Therapeutics | 54.62M |